Trial Profile
A phase III study of Actos combination drug in diabetic patients.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 May 2016
Price :
$35
*
At a glance
- Drugs Pioglitazone (Primary)
- Indications Diabetes mellitus
- Focus Therapeutic Use
- Sponsors Takeda
- 27 May 2016 New trial record